Multimerin-1 modulates macrophage M2 polarization and enhances tumor cell stemness in glioblastoma

MMRN1 is a critical BTSC-related biomarker that contributes to GBM progression by enhancing tumor stemness and modulating the immune microenvironment. Targeting MMRN1 May represent a promising therapeutic approach for GBM treatment.